← Browse by Condition
Medical Condition

solid tumor show to express dll3

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07174583 Phase 1, Phase 2
Recruiting

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Enrollment
208 pts
Location
United States, Austr...
Sponsor
IDEAYA Biosciences
View Trial →